Data / Research funding / Maryland / Technical Resources International, Inc.
Technical Resources International, Inc.: 16 NIH awards ($324.1M), fiscal years 2021 to 2026
Technical Resources International, Inc. in Bethesda, MD is funded under 16 NIH awards ($324.1M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- FAA2LVENETH4
- State
- Maryland
Awards
16 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| CLINICAL RESEARCH OPERATIONS AND MANAGEMENT SUPPORT (CROMS) - SARS CoV-2 Research | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $86,825,316 | April 17, 2017 | April 16, 2024 | HOLMES, MELYNDA | reporter.nih.gov |
| COVID-19: NIAID Regulatory Support Center | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $63,227,516 | April 15, 2023 | April 14, 2024 | RAFI, ASIMAH | reporter.nih.gov |
| DAIDS Quality Assurance, Quality Control and Inspection Readiness Support Services | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $51,529,857 | April 17, 2025 | April 16, 2026 | reporter.nih.gov | |
| DMID Clinical Research Operations & Management Support (CROMS): mpox activities | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $47,983,949 | April 1, 2024 | March 31, 2026 | ELLIS, JESSICA | reporter.nih.gov |
| IPP - DRUG DEVELOPMENT SUPPORT FOR CTEP | NIH | National Cancer Institute | 2022 to 2025 | $31,120,905 | July 1, 2022 | June 30, 2026 | MILLER, LAUREN | reporter.nih.gov |
| Regulatory Affairs Support | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $14,297,275 | July 1, 2022 | June 30, 2026 | HEREDIA, ELIZABETH | reporter.nih.gov |
| NIAID CLINICAL DATA AND SAFETY MANAGEMENT CENTER (CDSMC) | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $7,818,967 | September 15, 2021 | September 14, 2022 | MOLINA, DANIEL | reporter.nih.gov |
| DRUG DEVELOPMENT SUPPORT FOR THE CANCER THERAPY EVALUATION PROGRAM (CTEP) | NIH | National Cancer Institute | 2021 | $7,562,000 | July 1, 2015 | June 30, 2022 | SAUNDERS, JOAN | reporter.nih.gov |
| DMID REGULATORY AFFAIRS SUPPORT | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $3,723,712 | July 1, 2015 | June 30, 2022 | BUTLER, SANDRA | reporter.nih.gov |
| TASK ORDER 5A: CENTRALIZED PROTOCOL WRITING SUPPORT; CONTRACT TITLE: CANCER TRIALS SUPPORT UNIT CTSU. | NIH | National Cancer Institute | 2022 to 2025 | $3,136,859 | August 1, 2022 | July 31, 2025 | CARAVOULIAS, CHRISTINA | reporter.nih.gov |
| ACTIV-1 TIME-LIMITED BIOSPECIMEN STORAGE AND RELATED SERVICES (COVID-19), OPTION QUANTITY 1 STATISTICAL SUPPORT, OPTION QUANTITY 2 BIOSPECIMEN ANALYSI | NIH | National Center for Advancing Translational Sciences | 2022 | $2,701,936 | September 22, 2022 | September 21, 2025 | BUTLER, SANDRA | reporter.nih.gov |
| CANCER PREVENTION CLINICAL TRIALS AUDITING AND INFORMATICS SUPPORT | NIH | National Cancer Institute | 2021 to 2023 | $2,404,809 | May 16, 2019 | May 15, 2023 | MALLOY, DAVID | reporter.nih.gov |
| Preclinical and Translational Vaccine Development Support for HIV and Other Candidate Agents: Scientific, Quality and Regulatory Support Services | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $868,590 | August 8, 2025 | August 7, 2026 | MALLOY, DAVID | reporter.nih.gov |
| PHARMACOKINETIC ANALYSIS RESOURCE CENTER. PHASE I CLINICAL PHARMACOLOGY/PHARMACOKINETIC STUDY. JULY 23, 2025 - JANUARY 22, 2026. N01DA-25-8947. TASK ORDER 75N95025F00002 (TO2). | NIH | National Institute on Drug Abuse | 2025 | $489,558 | July 23, 2025 | January 22, 2026 | reporter.nih.gov | |
| CHANGE ORDER. PHASE I SINGLE ASCENDING DOSE STUDY. TO7. NIDA PHARMACOKINETIC ANALYSIS RESOURCE CENTER. 09/10/2024 - 03/09/2026. NIDA REF. NO. N01DA-19-8947. | NIH | National Institute on Drug Abuse | 2022 to 2025 | $253,950 | September 10, 2024 | March 9, 2026 | reporter.nih.gov | |
| CLINICAL TRIALS ACCRUAL QUALITY IMPROVEMENT PROGRAM (AQUIP) DATA AND INFORMATION TECHNOLOGY SUPPORT FOR THE US-LATIN AMERICAN-CARIBBEAN HIV/HPV PREVENTION CLINICAL TRIALS NETWORK (ULACNET) | NIH | National Cancer Institute | 2024 | $119,832 | June 3, 2024 | June 2, 2026 | KESSLAR, TIMOTHY | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 8 | $57,003,512 | 0 | $0 |
| 2024 | 7 | $59,856,736 | 0 | $0 |
| 2023 | 9 | $67,412,649 | 0 | $0 |
| 2022 | 10 | $66,640,285 | 0 | $0 |
| 2021 | 6 | $73,151,849 | 0 | $0 |
Topics of its NIH awards
- Infectious Diseases
- Clinical Research
- Clinical Trials and Supportive Activities
- HIV/AIDS
- Cancer
- Prevention
- Emerging Infectious Diseases
- Patient Safety
- Translational Research
- Biodefense and Related Countermeasures
- Coronaviruses
- Coronaviruses Therapeutics and Interventions
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.